Boniva vs. Reclast

See how Boniva and Reclast compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Boniva is a once-monthly oral tablet for postmenopausal osteoporosis, while Reclast is a once-yearly or once-every-two-years IV infusion approved for a wider range of bone conditions, including in men and steroid users.

  • Both drugs are nitrogen-containing bisphosphonates that slow bone breakdown, but Boniva's most common side effects involve digestion and muscles, while Reclast's center on a short-term flu-like reaction after the infusion.

  • The choice often comes down to how a patient prefers to take medication: a monthly pill at home with strict timing rules, or a yearly clinic visit with a chance of short-term flu-like symptoms.

Boniva vs. Reclast Drug Summary

Boniva

Boniva (ibandronate) is a nitrogen-containing bisphosphonate used to treat and prevent osteoporosis in postmenopausal women. It slows the natural breakdown of bone, which helps preserve bone density and lowers fracture risk. Boniva is taken as a tablet by mouth once a month, first thing in the morning on an empty stomach.

Reclast

Reclast (zoledronic acid) is a nitrogen-containing bisphosphonate used to treat and prevent osteoporosis in postmenopausal women, and it also treats men with osteoporosis, steroid-induced bone loss, and Paget's disease of bone. It works the same way as Boniva, slowing bone breakdown to protect bone density. Reclast is given as a single IV infusion, once a year for treatment or once every two years for prevention.

Boniva vs. Reclast Side Effects

Boniva

Most common
Myalgia (>5%)
Back pain (>5%)
Dyspepsia (>5%)
Pain in extremity (>5%)

Reclast

Most common
Myalgia (up to 17%)
Fever (up to 16%)
Fatigue (up to 12%)
Arthralgia (up to 11%)

Boniva vs. Reclast Dosage

Boniva

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 150 mg once monthly At the start
Maximum dose 150 mg once monthly Same as starting
Dose changes None Fixed dose

Reclast

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg IV infusion At the start
Maximum dose 5 mg IV infusion Same as starting
Dose changes None Fixed dose

Boniva vs. Reclast Indications

Boniva

Boniva is FDA-approved to treat and prevent osteoporosis in postmenopausal women. It works by slowing the natural breakdown of bone, which helps preserve bone density and lowers the risk of spine fractures. It is not approved for osteoporosis in men or for use in children.

  • Treatment of osteoporosis in postmenopausal women

  • Prevention of osteoporosis in postmenopausal women

  • Not approved for osteoporosis in men

  • Not approved for pediatric use

Reclast

Reclast is FDA-approved for a broader range of bone conditions than Boniva. It treats and prevents osteoporosis in postmenopausal women, increases bone mass in men with osteoporosis, treats and prevents glucocorticoid-induced osteoporosis, and treats Paget's disease of bone.

  • Treatment of osteoporosis in postmenopausal women

  • Prevention of osteoporosis in postmenopausal women

  • Increasing bone mass in men with osteoporosis

  • Treatment and prevention of glucocorticoid-induced osteoporosis

Boniva vs. Reclast Pros and Cons

Boniva

Boniva offers the convenience of a pill taken at home instead of a clinic visit, but its monthly schedule and strict dosing rules require more day-to-day effort than Reclast's yearly infusion. Coverage varies by plan, and prior authorization is common for either drug.

Pros

  • Taken as a pill at home, no clinic visit needed

  • No infusion-related flu-like reactions

  • Lower reported risk of acute kidney injury than IV bisphosphonates

  • Renal caution starts at a lower threshold than Reclast's contraindication

Cons

  • Must stay upright for 60 minutes after each dose

  • Requires an empty stomach and delayed breakfast each month

  • Not approved for men or pediatric osteoporosis

  • More frequent dosing (monthly) than Reclast's yearly infusion

Reclast

Reclast trades a daily or monthly pill routine for a single yearly (or less frequent) infusion, but that convenience comes with a clinic visit and a higher chance of short-term flu-like symptoms after each dose. Coverage typically falls under the medical benefit rather than a pharmacy plan.

Pros

  • Only one infusion per year, or every two years for prevention

  • Approved for men, steroid-induced osteoporosis, and Paget's disease

  • No fasting or upright-posture rules since it's given by IV

  • Given by a healthcare professional, removing at-home adherence guesswork

Cons

  • Requires an in-office IV infusion visit for each dose

  • Acute flu-like symptoms are common, especially after the first infusion

  • Contraindicated, not just cautioned, below 35 mL/min kidney function

  • Rare reports of acute kidney injury following infusion

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.